标题 |
The next-generation oral selective estrogen receptor degrader camizestrant (AZD9833) suppresses ER+ breast cancer growth and overcomes endocrine and CDK4/6 inhibitor resistance
新一代口服选择性雌激素受体降解剂camizestrant(AZD9833)抑制ER+乳腺癌生长并克服内分泌和CDK4/6抑制剂耐药性
|
网址 | |
DOI | |
求助人 | |
下载 |